Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

Dal - Gene

Project: Types of projects

View graph of relations
A Phase III, Double-blind, Randomized Placebo-controlled Study to Evaluate the Effects of Dalcetrapib on Cardiovascular (CV) Risk in a Genetically Defined Population With a Recent Acute Coronary Syndrome (ACS): The Dal-GenE Trial : NCT02525939


ID: 58247364